help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2006-0146
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/12/3165    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Avallone, R.
Right arrow Articles by Tremblay, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Avallone, R.
Right arrow Articles by Tremblay, A.
Molecular Endocrinology 20 (12): 3165-3178
Copyright © 2006 by The Endocrine Society

A Growth Hormone-Releasing Peptide that Binds Scavenger Receptor CD36 and Ghrelin Receptor Up-Regulates Sterol Transporters and Cholesterol Efflux in Macrophages through a Peroxisome Proliferator-Activated Receptor {gamma}-Dependent Pathway

Roberta Avallone1, Annie Demers1, Amélie Rodrigue-Way, Kim Bujold, Diala Harb, Silvia Anghel, Walter Wahli, Sylvie Marleau, Huy Ong and André Tremblay

Faculty of Pharmacy (R.A., A.D., K.B., D.H., S.M., H.O.), Pavillon Jean-Coutu, University of Montreal, Montréal, Québec, H3C 3J7 Canada; Research Center, Ste-Justine Hospital (R.A., A.D., A.R.-W., A.T.), and Departments of Biochemistry (A.R.-W., A.T.), and Obstetrics and Gynecology (A.T.), Faculty of Medicine, University of Montreal, Montreal, Québec, H3T 1C5 Canada; and Center for Integrative Genomics and National Center of Competence in Research Frontiers in Genetics (S.A., W.W.), University of Lausanne, CH-1015 Lausanne, Switzerland

Address all correspondence and requests for reprints to: André Tremblay, Research Center, Ste-Justine Hospital, 3175 Côte Ste-Catherine, Montréal (Québec), Canada H3T 1C5. E-mail: andre.tremblay{at}recherche-ste-justine.qc.ca; or Huy Ong, Pavillon Jean-Coutu, University of Montreal, Montréal (Québec), Canada H3C 3J7. E-mail: huy.ong{at}umontreal.ca.

Macrophages play a central role in the pathogenesis of atherosclerosis by accumulating cholesterol through increased uptake of oxidized low-density lipoproteins by scavenger receptor CD36, leading to foam cell formation. Here we demonstrate the ability of hexarelin, a GH-releasing peptide, to enhance the expression of ATP-binding cassette A1 and G1 transporters and cholesterol efflux in macrophages. These effects were associated with a transcriptional activation of nuclear receptor peroxisome proliferator-activated receptor (PPAR){gamma} in response to binding of hexarelin to CD36 and GH secretagogue-receptor 1a, the receptor for ghrelin. The hormone binding domain was not required to mediate PPAR{gamma} activation by hexarelin, and phosphorylation of PPAR{gamma} was increased in THP-1 macrophages treated with hexarelin, suggesting that the response to hexarelin may involve PPAR{gamma} activation function-1 activity. However, the activation of PPAR{gamma} by hexarelin did not lead to an increase in CD36 expression, as opposed to liver X receptor (LXR){alpha}, suggesting a differential regulation of PPAR{gamma}-targeted genes in response to hexarelin. Chromatin immunoprecipitation assays showed that, in contrast to a PPAR{gamma} agonist, the occupancy of the CD36 promoter by PPAR{gamma} was not increased in THP-1 macrophages treated with hexarelin, whereas the LXR{alpha} promoter was strongly occupied by PPAR{gamma} in the same conditions. Treatment of apolipoprotein E-null mice maintained on a lipid-rich diet with hexarelin resulted in a significant reduction in atherosclerotic lesions, concomitant with an enhanced expression of PPAR{gamma} and LXR{alpha} target genes in peritoneal macrophages. The response was strongly impaired in PPAR{gamma}+/– macrophages, indicating that PPAR{gamma} was required to mediate the effect of hexarelin. These findings provide a novel mechanism by which the beneficial regulation of PPAR{gamma} and cholesterol metabolism in macrophages could be regulated by CD36 and ghrelin receptor downstream effects.

NURSA Molecule Pages Link:

Nuclear Receptors:   PPARα  |  PPARδ  |  PPARγ  |  LXRβ  |  LXRα  |  RXRα
Ligands:   22α-Hydroxycholesterol  |  GW 9662  |  Pirinixic acid



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. Tesse, G. Al-Massarani, R. Wangensteen, S. Reitenbach, M. C. Martinez, and R. Andriantsitohaina
Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-{gamma} Agonist, Prevents Microparticle-Induced Vascular Hyporeactivity through the Regulation of Proinflammatory Proteins
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 539 - 547.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Rodrigue-Way, A. Demers, H. Ong, and A. Tremblay
A Growth Hormone-Releasing Peptide Promotes Mitochondrial Biogenesis and a Fat Burning-Like Phenotype through Scavenger Receptor CD36 in White Adipocytes
Endocrinology, March 1, 2007; 148(3): 1009 - 1018.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Iantorno, H. Chen, J.-a Kim, M. Tesauro, D. Lauro, C. Cardillo, and M. J. Quon
Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E756 - E764.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Sanchez, K. Sauve, N. Picard, and A. Tremblay
The Hormonal Response of Estrogen Receptor beta Is Decreased by the Phosphatidylinositol 3-Kinase/Akt Pathway via a Phosphorylation-dependent Release of CREB-binding Protein
J. Biol. Chem., February 16, 2007; 282(7): 4830 - 4840.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society